Literature DB >> 32119924

Single-Pass vs 2-Pass Endoscopic Ultrasound-Guided Fine-Needle Biopsy Sample Collection for Creation of Pancreatic Adenocarcinoma Organoids.

Joseph F Lacomb1, Dennis Plenker2, Hervé Tiriac2, Juan Carlos Bucobo1, Lionel S D'souza1, Asim S Khokhar1, Hardik Patel2, Breana Channer1, Dimitri Joseph1, Maoxin Wu3, David A Tuveson2, Ellen Li1, Jonathan M Buscaglia4.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) has one of the poorest prognoses of all malignancies, with a 5-year survival rate <8%.1,2 Suspicious lesions are typically diagnosed via endoscopic ultrasound-guided fine-needle aspiration or endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB).3 Fewer needle passes decreases the risk of postprocedure complications, including pancreatitis and hemorrhage, while allowing additional needle passes to be used for adjuvant tissue testing, such as organoid creation and DNA sequencing.
Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2020        PMID： 32119924      PMCID： PMC7483221          DOI： 10.1016/j.cgh.2020.02.045

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  7 in total

Review 1.  The Impact of Recent Advances in Endoscopic Ultrasound-Guided Tissue Acquisition on the Management of Pancreatic Cancer.

Authors:  Susana Marques; Miguel Bispo; Ricardo Rio-Tinto; Paulo Fidalgo; Jacques Devière
Journal:  GE Port J Gastroenterol       Date:  2020-10-23

Review 2.  The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine.

Authors:  Miguel Bispo; Susana Marques; Ricardo Rio-Tinto; Paulo Fidalgo; Jacques Devière
Journal:  GE Port J Gastroenterol       Date:  2020-09-07

Review 3.  Endoscopic ultrasound guided interventions in the management of pancreatic cancer.

Authors:  Tossapol Kerdsirichairat; Eun Ji Shin
Journal:  World J Gastrointest Endosc       Date:  2022-04-16

Review 4.  Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response.

Authors:  Geny Piro; Antonio Agostini; Alberto Larghi; Giuseppe Quero; Carmine Carbone; Annachiara Esposito; Gianenrico Rizzatti; Fabia Attili; Sergio Alfieri; Guido Costamagna; Giampaolo Tortora
Journal:  Front Med (Lausanne)       Date:  2021-12-23

5.  Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies.

Authors:  Jee Hyung Lee; Haeryoung Kim; Sang Hyub Lee; Ja-Lok Ku; Jung Won Chun; Ha Young Seo; Soon Chan Kim; Woo Hyun Paik; Ji Kon Ryu; Sang Kook Lee; Andrew M Lowy; Yong-Tae Kim
Journal:  Gut Liver       Date:  2021-12-17       Impact factor: 4.321

Review 6.  Endoscopic Ultrasound-Guided Sampling for Personalized Pancreatic Cancer Treatment.

Authors:  Eisuke Iwasaki; Seiichiro Fukuhara; Masayasu Horibe; Shintaro Kawasaki; Takashi Seino; Yoichi Takimoto; Hiroki Tamagawa; Yujiro Machida; Atsuto Kayashima; Marin Noda; Hideyuki Hayashi; Takanori Kanai
Journal:  Diagnostics (Basel)       Date:  2021-03-08

Review 7.  Impact of Endoscopic Ultrasound-Guided Tissue Acquisition on Decision-Making in Precision Medicine for Pancreatic Cancer: Beyond Diagnosis.

Authors:  Hiroshi Imaoka; Mitsuhito Sasaki; Yusuke Hashimoto; Kazuo Watanabe; Shoichi Miyazawa; Taro Shibuki; Shuichi Mitsunaga; Masafumi Ikeda
Journal:  Diagnostics (Basel)       Date:  2021-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.